Glycosmedia

Diabetes News Service

Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookies Policy
  • News
  • Archive
  • Categories & Tags
  • Journal Watch
  • Updates
  • Education
  • Reviews
  • About us ▼
    • About Glycosmedia
    • Editorial Team
    • Frequently asked questions
    • Comments
    • Press Releases
    • Disclaimer
  • Subscribe
  • Contact

Diabetes News

Category: Pharmay


Novo Nordisk to cease distribution of Tresiba® in Germany

July 1st 2015

Novo Nordisk announce that the company has decided to cease distribution of its once-daily basal insulin Tresiba® (insulin degludec) in Germany following a negative outcome of price negotiations with the GKV-Spitzenverband, the German national association of statutory health insurance funds

Categories: News, Pharma
Tags: Tresiba

Categories: Pharma
Tags: Tresiba

New Government report shows UK continues to lag in access to new medicines

March 31st 2015

The Government’s new Life Science Competitiveness Indicators – the publication which shows how well the UK performs internationally compared to other countries in the life sciences sector – shows that the UK continues to lag internationally in providing patients with access to new, innovative medicines (ABPI)

Categories: News, Pharma
Tags: ABPI

Categories: Pharma
Tags: ABPI

Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology

December 19th 2014

Eli Lilly and Company and Adocia announce a worldwide licensing collaboration focused on developing an ultra-rapid insulin, known as BioChaperone Lispro, for treatment in people with type 1 and type 2 diabetes

Categories: News, Pharma

Categories: Pharma

Adaptive pathways: a future approach to bring new medicines to patients?

December 15th 2014

Scientists argue that scientific and political changes will make adaptive pathways the preferred approach to make new treatments available (European Medicines Agency)

Categories: News, Pharma

Categories: Pharma

Merck Submits New Drug Application to the Japanese Pharmaceuticals and Medical Devices Agency for Omarigliptin, an Investigational Once-Weekly DPP-4 Inhibitor for Type 2 Diabetes

November 25th 2014

Japan is the first country with a regulatory filing for omarigliptin. Worldwide, Merck is supporting omarigliptin with a clinical development program that includes nine Phase 3 clinical trials involving approximately 7,500 patients with type 2 diabetes in support of planned regulatory filings (Merck)

Categories: News, Pharma

Categories: Pharma

The Access to Medicine Index 2014

November 17th 2014

The fourth Access to Medicine Index report provides a finely detailed picture of how the world’s 20 largest research-based pharmaceutical companies address access to medicine. (Access to Medicine Foundation)

Categories: News, Pharma

Categories: Pharma

New study to prevent type 1 diabetes planned for Diamyd Medical’s diabetes vaccine

October 24th 2014

A new study is planned for the Diamyd® diabetes vaccine that will comprise 80 children with high risk of presenting with type 1 diabetes. The aim is to test whether the diabetes vaccine can prevent or delay the onset in the children (Diamyd)

Categories: News, Pharma

Categories: Pharma

Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes

October 22nd 2014

Demonstrates Proof-of-Concept for ORMD-0801 Oral Insulin to Reduce Exogenous Insulin Requirements (Oramed Pharmaceuticals)

Categories: News, Pharma

Categories: Pharma

Sanofi Diabetes is on a mission to support children, parents and carers of children with type 1 diabetes through gaming

September 4th 2014

The New Mission T1D app, created by Sanofi Diabetes to address the need for greater understanding of T1D amongst children, parents and carers, friends and in the school environment is now available, free of charge, from the Apple UK store (Sanofi)

Categories: News, Pharma

Categories: Pharma

Mitsubishi Tanabe and AstraZeneca announce research collaboration in diabetic nephropathy

August 20th 2014

The three-year research collaboration will develop small molecule candidates from their respective portfolios (Mitsubishi Tanabe)

Categories: News, Pharma

Categories: Pharma

Sanofi and MannKind Announce Global Licensing Agreement for Afrezza® (insulin human) Rapid-Acting Inhaled Insulin

August 11th 2014

Sanofi and MannKind Corporation announced today that they have entered into a worldwide exclusive licensing agreement for development and commercialization of Afrezza® (insulin human) Inhalation Powder, a new rapid-acting inhaled insulin therapy for adults with type 1 and type 2 diabetes. The companies plan to launch Afrezza in the United States in the first quarter of 2015 (MannKind)

Categories: News, Pharma

Categories: Pharma

The price of medicines

July 31st 2014

Continuing an open and honest debate – Alison Clough, ABPI Executive Director – Commercial UK, responds to NICE Chairman, David Haslam’s, interview with Pharmafocus last month

Categories: News, Pharma

Categories: Pharma

Sanofi and Medtronic to Form Strategic Alliance in Diabetes to Improve Patient Experience and Outcomes

June 15th 2014

The alliance will initially focus on two key priorities: the development of drug-device combinations and delivery of care management services to improve adherence, simplify insulin treatment, and help people with diabetes better manage their condition (Sanofi)

Categories: News, Pharma

Categories: Pharma

Merck and Samsung Bioepis Enter Collaboration Agreement to Develop and Commercialize Insulin Glargine Candidate for Diabetes

February 10th 2014

MSD and Samsung Bioepis announce that they have expanded their collaboration with an agreement to develop, manufacture and commercialize MK-1293, an insulin glargine candidate for the treatment of patients with type 1 and type 2 diabetes. Phase III clinical studies in type 1 and type 2 diabetes will begin soon (Merck)

Categories: News, Pharma

Categories: Pharma

AstraZeneca completes the acquisition of Bristol-Myers Squibb share of global diabetes alliance

February 3rd 2014

AstraZeneca announce that it completed, on 1 February 2014, the acquisition of the entirety of Bristol-Myers Squibb’s interests in the companies’ diabetes alliance (AstraZeneca)

Categories: News, Pharma

Categories: Pharma

Oramed Announces Successful FDA Phase 2a Clinical Trial Results

January 30th 2014

A Phase 2a clinical trial for ORMD-0801 oral insulin capsule for the treatment of type 2 diabetes met all primary and secondary endpoints (Oramed)

Categories: News, Pharma

Categories: Pharma

Bristol-Myers Squibb – Sale of Its Diabetes Business

December 19th 2013

Bristol-Myers Squibb Company announce that it has signed an agreement to sell its global diabetes business that was part of its collaboration with AstraZeneca (Bristol-Myers Squibb)

Categories: News, Pharma

Categories: Pharma

Bristol, AstraZeneca withdraw diabetes drug in Germany

December 15th 2013

Bristol-Myers Squibb and AstraZeneca said they would pull a new diabetes drug from the German market because they had failed to agree on a price with a body of medical insurers. The decision to stop marketing oral drug dapagliflozin in Germany comes just a day after it was endorsed by an advisory panel to the U.S. Food and Drug Administration (Reuters)

Categories: News, Pharma

Categories: Pharma

MannKind Resubmits New Drug Application to U.S. FDA for AFREZZA

October 15th 2013

MannKind Corporation announces the resubmission of a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for the marketing and sale of AFREZZA® (insulin human [rDNA origin]) Inhalation Powder with an indication to improve glycemic control in adults with type 1 or type 2 diabetes (MannKind Corporation)

Categories: News, Pharma

Categories: Pharma

Novo Nordisk’s diabetes combination IDegLira impresses in study

September 27th 2013

Mix of Tresiba and Victoza helps 81 per cent achieve blood sugar target in phase III (PMLive)

Categories: News, Pharma

Categories: Pharma
  • 1
  • 2
  • 3
  • Next Page »

Subscribe

subscribe-iconFREE weekly updates by email Please CLICK HERE

Platinum Sponsors

Boehringer Ingelheim Lilly

Gold Sponsors

Sanofi DiabetesNovo NordiskNapp DiabetesAstraZeneca

Silver Sponsors

AmgenAbbott Diabetes CareWelsh Endocrinology and Diabetes Society (WEDS)

FUNDING NOTICE

The Glycosmedia website and newsletter has been made possible with funding support from our sponsors. None of our sponsors have control over the content of the website, newsletter, apps, Twitter feed or RSS newsfeed.

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com

Advertisers

CRC Press

The organisations advertising in this section do not have any input into, or editorial control over the content of this website.

Categories

  • Audits
  • Bariatric
  • Biochemistry
  • Cardiovascular
  • Devices
  • Diagnosis
  • Diet
  • Education
  • Epidemiology
  • Genetics
  • Gestational
  • Guidance
  • Guidelines
  • Hepatology
  • Hypertension
  • Immunology
  • Management
  • Media
  • Medication
  • Meetings
  • Monitoring
  • Nephrology
  • Neuropathy
  • Nephropathy
  • Obesity
  • Ophthalmology
  • Paediatrics
  • Pathology
  • Pharma
  • Pharmacology
  • Physiology
  • Podiatry
  • Prediabetes
  • Prevalence
  • Prevention
  • Psychological
  • Reports
  • Research
  • Screening
  • Sponsorship
  • Technology
  • Testing
  • Transplantation
  • Treatment
  • Wound Care

To see all articles associated with a category just click on the category name.

Popular Tags

ADA BMI canagliflozin CGM CKD closed-loop COVID-19 dapagliflozin DPP4 elderly Empagliflozin exenatide exercise GLP1 glycaemic control HbA1c heart failure hyperglycemia hypoglycemia incretin insulin insulin pump Insulin resistance Ketoacidosis lada liraglutide metformin microvascular mortality NICE pioglitazone retinopathy semaglutide SGLT2 inhibitors sitagliptin statin sulfonylureas Type 1 Diabetes Type 2 Diabetes Vitamin D

To see all articles associated with a tag just click on the tag name.

Complete list of Tags ››

Join us on Facebook

Join us on Facebook

Please share Glycosmedia:

Follow us on Twitter

My Tweets

mobileGlycosmedia is also available as an App:

For iPhone and iPad | For Android devices


Sponsorship and Advertising

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com

Copyright © 2021 Glycosmedia Partnership